A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Sunday, 8 July 2012

Telmisartan + hctz: combination SPC in Spain -- now in English

Pamplona: city of great
excitement -- even for SPCs
Last month, in "Telmisartan + hctz: combination SPC revoked in Spain" (here), Javier Huarte and his colleague Sara Pelaz (Grau & Angulo, Barcelona) kindly sent us information concerning a judgment of the Commercial Court No. 1 of Pamplona, which upheld a revocation action by Cinfa and Actavis against the Spanish SPC for telmisartan + hctz.


Javier and Sara have now sent us an English translation of this decision, which you can read here.  Thanks so much, Javier and Sara, for your thoughtfulness.

No comments: